259 results on '"Pearson, Glen J."'
Search Results
2. Consideration and Application of Lipoprotein(a) in the Risk Assessment of Atherosclerotic Cardiovascular Disease Risk in Adults
3. Ligne directrice C-CHANGE pour l'harmonisation des lignes directrices nationales de prevention et de prise en charge des maladies cardiovasculaires en contexte de soins primaires au Canada : mise a jour 2022
4. Canadian Cardiovascular Harmonized National Guideline Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2022 update
5. Assessment of immunosuppression induction with basiliximab compared to antithymocyte‐globulin in adult heart transplant patients
6. Personalizing cardiovascular risk: Coronary artery calcium scans to improve statin use in adults with type 2 diabetes can be cost‐effective in select individuals
7. Increased Lp(a) Workload Volumes Reflect Uptake of the 2021 Canadian Cardiovascular Society Guidelines for Management of Dyslipidemia
8. Reply to Logan et al.—Explaining the TG Cutoff in the 2021 Lipid Guidelines for When Clinicians Should Rely on Non-HDL-C or ApoB
9. The Canadian Consensus Working Group’s Approach to Identifying and Managing Statin-Associated Muscle and Other Symptoms
10. 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults
11. Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018
12. Pharmacologic Treatment of Patients With Myocardial Ischemia With No Obstructive Coronary Artery Disease
13. Pharmacist-Led Follow-Up Program for Rural Patients with Acute Coronary Syndrome: The PLURAL-ACS Pilot Program.
14. 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
15. Updated guidelines for the management of dyslipidemia and the prevention of cardiovascular disease in adults by pharmacists
16. Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016)
17. Correlation of cardiovascular magnetic resonance imaging findings and endomyocardial biopsy results in patients undergoing screening for heart transplant rejection
18. Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update
19. Remote Pharmacist Practice Model of Collaboration in Primary Care: Potential for Benefit or an Opportunity Lost?
20. Frequency of Intensive Statin Therapy in Patients With Acute Coronary Syndrome Admitted to a Tertiary Care Center
21. Omega-3 fatty acids for cardiovascular disease prevention: A practice tool for pharmacists
22. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations
23. Evaluation of Preventive Cardiovascular Pharmacotherapy after Coronary Artery Bypass Graft Surgery
24. Lipid therapy: A new whiteboard video for patient education
25. The clinical effect and tolerability of ezetimibe in high-risk patients managed in a specialty cardiovascular risk reduction clinic
26. Association Between Hemoglobin A1c and Major Adverse Coronary Events in Patients with Diabetes Following Coronary Artery Bypass Surgery
27. Comparison of Preventive Cardiovascular Pharmacotherapy in Surgical vs Percutaneous Coronary Revascularization
28. Making Hospital Pharmacists Indispensable on the Healthcare Team: Revolution in Waiting
29. Supplementary_Materials_(3) – Supplemental material for Switching to Clopidogrel in Patients With Acute Coronary Syndrome Managed With Percutaneous Coronary Intervention Initially Treated With Prasugrel or Ticagrelor: Systematic Review and Meta-analysis
30. Cardiovascular Efficacy and Safety of PCSK9 Inhibitors: Systematic Review and Meta-analysis Including the ODYSSEY OUTCOMES Trial
31. Evolution in the practice of pharmacy—not a revolution!
32. Pretransplant Diabetes, Not Donor Age, Predicts Long-Term Outcomes in Cardiac Transplantation
33. The 2018 ACC/AHA Lipid Guidelines: A Little More or Less Canadian?
34. Switching to Clopidogrel in Patients With Acute Coronary Syndrome Managed With Percutaneous Coronary Intervention Initially Treated With Prasugrel or Ticagrelor: Systematic Review and Meta-analysis
35. Case Report: Treatment of Blastomycosis with Fluconazole
36. A review of the use of direct oral anticoagulant use in orthotopic heart transplantation recipients
37. Proprotein convertase subtilisin/kexin type 9 inhibitors for reduction of cardiovascular events
38. Prevention and management of statin adverse effects: A practical approach for pharmacists
39. Comment: Should an LDL Cholesterol Target–Based Approach Be Readopted?
40. Hypercholestérolémie familiale: Révision du diagnostic, du dépistage et du traitement
41. Le passé, le présent et un avenir très radieux
42. The Past, the Present, and a Very Bright Future
43. 2016 Guidelines for the management of dyslipidemia and the prevention of cardiovascular disease in adults by pharmacists
44. The Pursuit of Professional Practice Excellence and the Achievement of Peer Recognition
45. La recherche de l’excellence en pratique professionnelle et l’obtention de la reconnaissance des pairs
46. New Antilipid Drugs: Do the Known Benefits Justify the Expense?
47. A randomized trial of a community-based approach to dyslipidemia management
48. Faire partie de la SCPH – un investissement dans votre avenir et celui de la pharmacie hospitalière!
49. Belonging to CSHP—An Investment in Your Future and That of Hospital Pharmacy!
50. Evaluation of the Management of Hyperlipidemia and Hypertension in an Outpatient Cardiac Transplant Clinic
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.